Literature DB >> 27543917

Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.

P Dusek1,2, E Bahn3, T Litwin4, K Jabłonka-Salach5, A Łuciuk5, T Huelnhagen6, V I Madai7, M A Dieringer6,8, E Bulska5, M Knauth1, T Niendorf6,8, J Sobesky7,8, F Paul8,9, S A Schneider10,11, A Czlonkowska4,12, W Brück3, C Wegner3, J Wuerfel1,9,13.   

Abstract

AIMS: In Wilson disease (WD), T2/T2*-weighted (T2*w) MRI frequently shows hypointensity in the basal ganglia that is suggestive of paramagnetic deposits. It is currently unknown whether this hypointensity is related to copper or iron deposition. We examined the neuropathological correlates of this MRI pattern, particularly in relation to iron and copper concentrations.
METHODS: Brain slices from nine WD and six control cases were investigated using a 7T-MRI system. High-resolution T2*w images were acquired and R2* parametric maps were reconstructed using a multigradient recalled echo sequence. R2* was measured in the globus pallidus (GP) and the putamen. Corresponding histopathological sections containing the lentiform nucleus were examined using Turnbull iron staining, and double staining combining Turnbull with immunohistochemistry for macrophages or astrocytes. Quantitative densitometry of the iron staining as well as copper and iron concentrations were measured in the GP and putamen and correlated with R2* values.
RESULTS: T2*w hypointensity in the GP and/or putamen was apparent in WD cases and R2* values correlated with quantitative densitometry of iron staining. In WD, iron and copper concentrations were increased in the putamen compared to controls. R2* was correlated with the iron concentration in the GP and putamen, whereas no correlation was observed for the copper concentration. Patients with more pronounced pathological severity in the putamen displayed increased iron concentration, which correlated with an elevated number of iron-containing macrophages.
CONCLUSIONS: T2/T2*w hypointensity observed in vivo in the basal ganglia of WD patients is related to iron rather than copper deposits.
© 2016 British Neuropathological Society.

Entities:  

Keywords:  Wilson disease; brain; iron accumulation; pathology; post mortem 7T MRI

Mesh:

Substances:

Year:  2016        PMID: 27543917     DOI: 10.1111/nan.12341

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  17 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

Review 4.  Sleep Disorders in Wilson's Disease.

Authors:  Valérie Cochen De Cock; France Woimant; Aurélia Poujois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

Review 5.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

6.  Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease.

Authors:  Xiang-Zhen Yuan; Gai-Ying Li; Jia-Lin Chen; Jian-Qi Li; Xiao-Ping Wang
Journal:  Front Neurosci       Date:  2020-09-16       Impact factor: 4.677

7.  Multimodal assessment of nigrosomal degeneration in Parkinson's disease.

Authors:  Jason Langley; Daniel E Huddleston; Bruce Crosson; David D Song; Stewart A Factor; Xiaoping Hu
Journal:  Parkinsonism Relat Disord       Date:  2020-09-16       Impact factor: 4.891

Review 8.  Sleep Abnormalities in Wilson's Disease.

Authors:  Valérie Cochen De Cock; Nadège Girardot-Tinant; France Woimant; Aurélia Poujois
Journal:  Curr Treat Options Neurol       Date:  2018-09-27       Impact factor: 3.598

9.  Optical coherence tomography as a marker of neurodegeneration in patients with Wilson's disease.

Authors:  Ewa Langwińska-Wośko; Tomasz Litwin; Karolina Dzieżyc; Michał Karlinski; Anna Członkowska
Journal:  Acta Neurol Belg       Date:  2017-05-09       Impact factor: 2.396

10.  Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plasma Mass Spectrometry.

Authors:  Philipp Kim; Chengcheng Christine Zhang; Sven Thoröe-Boveleth; Sabine Weiskirchen; Nadine Therese Gaisa; Eva Miriam Buhl; Wolfgang Stremmel; Uta Merle; Ralf Weiskirchen
Journal:  Biomedicines       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.